"Critical Pharmaceuticals, the speciality pharmaceuticals company, today announced that it had ecured a £1.5m translation award from the Wellcome Trust to develop a nasal spray of Human Growth Hormone (hGH) using its proprietary CriticalSorb technology as an alternative to injection. hGH, a leading biological drug for the treatment of growth disorders had global sales of $2.8bn in 2007."
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment